相似文献
1
UTILIZTION OF THE SUZUKI COUPLING TO ENHANCE THE ANTITUBERCULOSIS ACTIVITY OF ARYL OXAZOLES.利用铃木耦合反应增强芳基恶唑类化合物的抗结核活性
Heterocycles. 2010 Mar 1;80(2):977-988. doi: 10.3987/COM-09-S(S)69.
2
Structure-activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters.新型含恶唑啉和恶唑烷酮苄酯的抗结核药物的构效关系。
Eur J Med Chem. 2010 May;45(5):1703-16. doi: 10.1016/j.ejmech.2009.12.074. Epub 2010 Jan 14.
3
A Facile Synthesis of 2-Oxazolines via Dehydrative Cyclization Promoted by Triflic Acid.三氟磺酸促进脱水环化合成 2-恶唑啉的简便方法。
Molecules. 2022 Dec 19;27(24):9042. doi: 10.3390/molecules27249042.
4
Synthesis of 2-phenyl-4,5-substituted oxazoles by copper-catalyzed intramolecular cyclization of functionalized enamides.铜催化功能化烯酰胺的分子内环化合成 2-苯基-4,5-取代恶唑。
J Org Chem. 2012 Dec 7;77(23):10752-63. doi: 10.1021/jo3021192. Epub 2012 Nov 16.
5
Palladium-catalysed arylative cyclisation of N-allylacetamides with aryl halides yielding benzyl-substituted oxazolines.钯催化 N-烯丙基乙酰胺与芳基卤化物的芳基化环化反应，生成苄基取代的恶唑啉。
Chem Commun (Camb). 2009 Oct 14(38):5754-6. doi: 10.1039/b912895f. Epub 2009 Sep 3.
6
A new thioglycolic ester β-cyclodextrin/PdCl in water: An accessible catalyst for the Suzuki-Miyaura coupling reaction.水中新型硫代乙醇酸酯β-环糊精/PdCl：一种用于铃木-宫浦偶联反应的易得催化剂。
Carbohydr Polym. 2023 Feb 1;301(Pt A):120271. doi: 10.1016/j.carbpol.2022.120271. Epub 2022 Oct 28.
7
The rapid synthesis of oxazolines and their heterogeneous oxidation to oxazoles under flow conditions.唑啉的快速合成及其在流动条件下的非均相氧化生成唑类化合物。
Org Biomol Chem. 2015 Jan 7;13(1):207-14. doi: 10.1039/c4ob02105c.
8
Preparation of 2,5-disubstituted oxazoles from N-propargylamides.由N-炔丙基酰胺制备2,5-二取代恶唑
Org Lett. 2001 Aug 9;3(16):2501-4. doi: 10.1021/ol016133m.
9
Synthesis of 2-Oxazolines by in Situ Desilylation and Cyclodehydration of β-Hydroxyamides.通过β-羟基酰胺的原位脱硅和环脱水合成2-恶唑啉
J Org Chem. 2015 Jan 2;80(1):40-51. doi: 10.1021/jo5016695. Epub 2014 Dec 18.
10
Synthesis of functionalized oxazolines and oxazoles with DAST and Deoxo-Fluor.利用DAST和Deoxo-Fluor合成功能化恶唑啉和恶唑
Org Lett. 2000 Apr 20;2(8):1165-8. doi: 10.1021/ol005777b.
引用本文的文献
1
Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds.新型抗结核药物的研发：噁唑啉、噁唑、噻唑啉、噻唑类到咪唑并[1,2-a]吡啶和异构 5,6-稠合骨架的优化。
Bioorg Med Chem. 2012 Apr 1;20(7):2214-20. doi: 10.1016/j.bmc.2012.02.025. Epub 2012 Feb 16.
2
Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity.具有强效多重和广泛耐药抗结核活性的咪唑并[1,2-a]吡啶-3-甲酰胺的问世。
ACS Med Chem Lett. 2011 Jun 9;2(6):466-470. doi: 10.1021/ml200036r.
3
N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide as a new scaffold that provides rapid access to antimicrotubule agents: synthesis and evaluation of antiproliferative activity against select cancer cell lines.N-((1-苄基-1H-1,2,3-三唑-4-基)甲基)芳酰胺作为一种新的支架，为合成抗微管药物提供了快速途径：对选定癌细胞系的抗增殖活性的合成和评价。
J Med Chem. 2010 Apr 22;53(8):3389-95. doi: 10.1021/jm1000979.
4
Structure-activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters.新型含恶唑啉和恶唑烷酮苄酯的抗结核药物的构效关系。
Eur J Med Chem. 2010 May;45(5):1703-16. doi: 10.1016/j.ejmech.2009.12.074. Epub 2010 Jan 14.
本文引用的文献
1
Structure-activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters.新型含恶唑啉和恶唑烷酮苄酯的抗结核药物的构效关系。
Eur J Med Chem. 2010 May;45(5):1703-16. doi: 10.1016/j.ejmech.2009.12.074. Epub 2010 Jan 14.
2
Utilization of microbial iron assimilation processes for the development of new antibiotics and inspiration for the design of new anticancer agents.利用微生物铁同化过程开发新型抗生素并为新型抗癌药物设计提供灵感。
Biometals. 2009 Feb;22(1):61-75. doi: 10.1007/s10534-008-9185-0. Epub 2009 Jan 7.
3
Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis.药物与病菌：追寻宿敌结核分枝杆菌
Nat Rev Microbiol. 2008 Jan;6(1):41-52. doi: 10.1038/nrmicro1816.
4
Synthesis and studies of catechol-containing mycobactin S and T analogs.含儿茶酚的分枝杆菌素S和T类似物的合成与研究
Org Biomol Chem. 2007 May 21;5(10):1621-8. doi: 10.1039/b703116e. Epub 2007 Apr 19.
5
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.用于高通量筛选抗非复制型结核分枝杆菌化合物的低氧恢复试验
Antimicrob Agents Chemother. 2007 Apr;51(4):1380-5. doi: 10.1128/AAC.00055-06. Epub 2007 Jan 8.
6
WHO policies for tuberculosis control.世界卫生组织结核病控制政策。
Lancet. 2004 Jun 5;363(9424):1911. doi: 10.1016/S0140-6736(04)16377-0.
7
Improved green fluorescent protein reporter gene-based microplate screening for antituberculosis compounds by utilizing an acetamidase promoter.利用乙酰胺酶启动子改进基于绿色荧光蛋白报告基因的抗结核化合物微孔板筛选。
Antimicrob Agents Chemother. 2003 Dec;47(12):3682-7. doi: 10.1128/AAC.47.12.3682-3687.2003.
8
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis.一种用于治疗结核病的小分子硝基咪唑并吡喃候选药物。
Nature. 2000 Jun 22;405(6789):962-6. doi: 10.1038/35016103.
9
Synthesis of functionalized oxazolines and oxazoles with DAST and Deoxo-Fluor.利用DAST和Deoxo-Fluor合成功能化恶唑啉和恶唑
Org Lett. 2000 Apr 20;2(8):1165-8. doi: 10.1021/ol005777b.
10
The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages.结核分枝杆菌中源自水杨酸盐的分枝杆菌铁载体对于在巨噬细胞中的生长至关重要。
Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1252-7. doi: 10.1073/pnas.97.3.1252.
Zotero 插件